РЕККУРЕНТНАЯ ПРЕЭКЛАМПСИЯ
Аннотация
Рецидивирующая преэклампсия представляет собой одну из наиболее клинически значимых форм гипертензивных осложнений беременности, ассоциированную с повышенными рисками как для матери, так и для плода. Повторное развитие преэклампсии требует особого внимания с точки зрения патогенетического понимания, ранней идентификации факторов риска и разработки профилактических подходов. Материалы и методы. В настоящем обзоре проанализирована современная литература с использованием баз данных PubMed, Scopus, Web of Science, ScienceDirect и Cochrane Library. В анализ включены оригинальные исследования, систематические обзоры, метаанализы и клинические рекомендации, опубликованные преимущественно за последние 10 лет. Особое внимание уделено работам, посвящённым рецидивам преэклампсии, их долгосрочным последствиям, а также индивидуализированным стратегиям ведения.
Ключевые слова:
Об авторах
Список литературы
Elizabeth M.C., Sara N.I., Katherine L.G. et al. Early preterm preeclampsia outcomes by intended mode of delivery. Am J Obstet Gynecol. 2019 Jan;220(1):100.e1‑100.e9.
Roberge S., Bujold E., Nicolaides K.H. et al. Aspirin for the prevention of preterm and term preeclampsia: systematic review and meta‑analysis. Am J Obstet Gynecol. 2018;218:287‑293. DOI: 10.1016/j.ajog.2017.11.561.
Rahnemaei F.A., Fashami M.A., Abdi F. et al. Factors effective in the prevention of preeclampsia: a systematic review. Taiwan J Obstet Gynecol. 2020;59:173‑182. DOI: 10.1016/j.tjog.2020.01.002.
Espinoza J., Vidaeff A., Pettker C.M. et al. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135:E237‑E260. DOI: 10.1097/AOG.0000000000003891.
Mou A.D., Barman Z., Hasan M. et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11:21339. DOI: 10.1038/s41598‑021‑00839‑w.
Benschop L., Schelling S.J.C., Duvekot J.J. et al. Cardiovascular health and vascular age after severe pre‑eclampsia: a cohort study. Atherosclerosis. 2020;292:136‑142. DOI: 10.1016/j.atherosclerosis.2019.11.023. PMID: 31805453.
Brouwers L., van der Meiden‑van Roest A.J., Savelkoul C. et al. Recurrence of pre‑eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta‑analysis. BJOG. 2018;125(13):1642‑1654. DOI: 10.1111/1471‑0528.15394. PMID: 29978553.
Witvrouwen I., Mannaerts D., Van Berendoncks A.M. et al. The effect of exercise training during pregnancy to improve maternal vascular health: focus on gestational hypertensive disorders. Front Physiol. 2020;11:450. DOI: 10.3389/fphys.2020.00450.
Perry A., Stephanou A., Rayman M.P. et al. Dietary factors that affect the risk of pre‑eclampsia. BMJ Nutr Prev Health. 2022;5:118‑133. DOI: 10.1136/bmjnph‑2021‑000399.
Jayet P.Y., Rimoldi S.F., Stuber T. et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation. 2010;122.
Brown M.A., Magee L.A., Kenny L.C. et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291‑310. DOI: 10.1016/j.preghy.2018.05.004.
Voskamp L., Rousian M., Koerts J.J. et al. Risk factors for chronic hypertension 5 years after a pregnancy complicated by preeclampsia: a systematic review and meta‑analysis. J Hypertens. 2024;42(Suppl 1):e56. DOI: 10.1097/01.hjh.0001019792.36399.31.
Dong X., Han M., Zeb S. et al. Active management reduces the incidence of recurrent pre-eclampsia and improves maternal and fetal outcomes in women with recurrent pre-eclampsia. Front Med. 2021;8:658022. DOI: 10.3389/fmed.2021.658022.
Steinthorsdóttir V., McGinnis R., Williams N.O. et al. Genetic predisposition to hypertension is associated with pre-eclampsia in European and Central Asian women. Nat Commun. 2020;11:5976. DOI: 10.1038/s41467-020-19733-6.
Kivioja A., Toivonen E., Tyrmi J. et al. Increased risk of preeclampsia in women with a genetic predisposition to elevated blood pressure. Hypertension. 2022;79(9):2008–2015. DOI: 10.1161/HYPERTENSIONAHA.122.18996. PMID: 35862124.
Chaemsaithong P., Sahota D.S., Poon L.C. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226:S1071–S1097.e2. DOI: 10.1016/j.ajog.2020.07.020.
Von Dadelszen P., Magee L.A., Roberts J.M. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143–148. DOI: 10.1081/PRG-120021060.
Cunningham F.G., Leveno K.J., Bloom S.L. et al. Williams Obstetrics. 25th ed. New York: McGraw Hill; 2022. p. 1086–1089.
Zhang M., Wan P., Ng K. et al. Preeclampsia among African American pregnant women: an update on prevalence, complications, etiology, and biomarkers. Obstet Gynecol Surv. 2020;75:111–120. DOI: 10.1097/OGX.0000000000000747.
Arzikulov A.Sh., Rasul-Zade Y.G., Meliyeva D.A., Arzibekov A.G. Outcomes of perinatal pathology in neonates of mothers with preeclampsia. //Perinatology - Journal of Perinatal and Neonatal Care.-2025.-V.26, Issue 1.-P.23-28.
Arzikulov A.Sh., Rasul-Zade Y.G, Melieva, D. A., Arzibekov A.G. Outcomes of Perinatal phatology in Newborn from mothers with Earli Pre-Eclampsia. American Journal of Medicine and Medical Sciences 2024, 14(8): 2070-2073
DOI: 10.5923/j.ajmms.20241408.26
Baroutis D., Katsianou E., Athanasiou D. et al. DASH Diet and Preeclampsia Prevention: A Literature Review. Nutrients. 2025;17(12):2025. DOI: 10.3390/nu17122025. PMID: 40573136.
Committee on Practice Bulletins—Obstetrics. Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. Obstet Gynecol. 2020;135(6):e237–e260. DOI: 10.1097/AOG.0000000000003891. PMID: 32443079.
de Oliveira L.F., Bernardes K.R., do Nascimento J.H.M. et al. Predictive value of first trimester serum markers and uterine artery Doppler for preeclampsia: a systematic review and meta-analysis. Front Cardiovasc Med. 2020;7:423. DOI: 10.3389/fcvm.2020.00423. PMID: 32850936.
Yang Y., Wu N. Gestational diabetes mellitus and preeclampsia: correlation and influencing factors. Front Cardiovasc Med. 2022;9:831297. DOI: 10.3389/fcvm.2022.831297. PMID: 35252402.
Duhig K., Vandermolen B., Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000Res. 2018;7:242. DOI: 10.12688/f1000research.12249.1.
Yang Y., Le Ray I., Zhu J. et al. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021;4:e218401. DOI: 10.1001/jamanetworkopen.2021.8401.
Zhang M., Wan P., Ng K. et al. Preeclampsia among African American pregnant women: an update on prevalence, complications, etiology, and biomarkers. Obstet Gynecol Surv. 2020;75:111–120. DOI: 10.1097/OGX.0000000000000747.
Johnson J.D., Louis J.M. Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature. Am J Obstet Gynecol. 2022;226:S876–S885. DOI: 10.1016/j.ajog.2020.07.038.
Dröge L.A., Perschel F.H., Stütz N. et al. Prediction of preeclampsia-related adverse outcomes with the sFlt-1/PlGF ratio in clinical routine: a real-world study. Hypertension. 2021;77(2):461–471.
DOI:10.1161/HYPERTENSIONAHA.120.15146.
Carver S., Rix C., Hauptmann M. et al. Impact of maternal antiangiogenic profile on early motor development of preterm infants. Front Endocrinol. 2021;12:913514. DOI: 10.3389/fendo.2021.913514.
Chatzakis C., Liberis A., Zavlanos A. et al. Early delivery versus expectant management for late preterm preeclampsia: meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 2021;100(8):1392–1400. DOI: 10.1111/aogs.14149.
Society for Maternal-Fetal Medicine, Louis J.M., Parchem J.G. et al. Report and recommendations of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation on preeclampsia. Am J Obstet Gynecol. 2022;227(5 Suppl B):B2–B20. DOI: 10.1016/j.ajog.2022.07.001.
Sheen J.-J., Huang Y., Andrikopoulou M. et al. Maternal age and preeclampsia outcomes during delivery hospitalizations. Am J Perinatol. 2020;37:44–52. DOI: 10.1055/s-0039-1694794.
Tyas B.D., Lestari P., Akbar M.I.A. Maternal perinatal outcomes related to advanced maternal age in preeclampsia pregnant women. J Family Reprod Health. 2019;13:191–200. DOI: 10.18502/jfrh.v13i4.2646.
Mayrink J., Souza R.T., Feitosa F.E. et al. Incidence and risk factors for preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control study. Sci Rep. 2019;9:9517. DOI: 10.1038/s41598-019-46011-3.
Как цитировать
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.